drugset / Trial / NCT00087113

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

NCT00087113 ↗

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as pemetrexed disodium, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well pemetrexed disodium works in treating patients with recurrent cancer of the cervix.

Timeline

Start
2004-08
Primary completion
2006-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Pemetrexed Small molecule 900 mg/m2 Intravenous

Indications